Stay updated on Safety of Sotatercept in Beta-Thalassemia Clinical Trial
Sign up to get notified when there's something new on the Safety of Sotatercept in Beta-Thalassemia Clinical Trial page.

Latest updates to the Safety of Sotatercept in Beta-Thalassemia Clinical Trial page
- Check6 days agoChange DetectedFooter updated to display 'Revision: v3.3.3'; the 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' links were removed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed.SummaryDifference0.0%

- Check42 days agoChange DetectedRemoved the government funding lapse notice that warned updates may not be current. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check57 days agoChange DetectedNo significant additions or deletions detected on the Study Details page; the content appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check85 days agoChange DetectedSummary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

- Check93 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

Stay in the know with updates to Safety of Sotatercept in Beta-Thalassemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Sotatercept in Beta-Thalassemia Clinical Trial page.